Details for Patent: 11,439,629
✉ Email this page to a colleague
Which drugs does patent 11,439,629 protect, and when does it expire?
Patent 11,439,629 protects INGREZZA and is included in one NDA.
This patent has seventy patent family members in eleven countries.
Drugs Protected by US Patent 11,439,629
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-001 | Apr 11, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Try a Trial | ||||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-003 | Apr 23, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Try a Trial | ||||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-002 | Oct 4, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,439,629
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2017395700 | ⤷ Try a Trial | |||
Australia | 2017395701 | ⤷ Try a Trial | |||
Australia | 2017395702 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |